Platinum Asset Management is a Sydney-based Australian investment manager and institutional investor focused on actively managed equity strategies across international, Asia, Japan, European, technology, brands and health sciences mandates. Its private-market activity includes later-stage venture participation in biotechnology, including Germany-linked exposure. The firm is most relevant for companies seeking institutional equity capital where life sciences, TMT, and Australia, Europe, Asia, Japan or Germany investment coverage are relevant.